DABCO-BBAC Nanoparticles for Gene Delivery and Antibacterial Action

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gene delivery methods face challenges in transporting large molecules and protecting nucleic acids from degradation, and existing antibacterial agents are often ineffective against drug-resistant bacteria, necessitating the development of safe, efficient, and multifunctional nanoparticles for both gene and drug delivery and antibacterial purposes.

Innovation Solution

The synthesis of cationic multifunctional copolymeric nanoparticles using 1,4-diazabicyclo[2.2.2]octane (DABCO) monomers crosslinked with bromoacetyl cystamine (BBAC) monomers, which are redox-sensitive, have antibacterial activity, and can deliver nucleic acids into cells while minimizing toxicity to mammalian cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If viral vectors are used as carriers for gene delivery, then transmission efficiency is improved, but inflammation and immune system stimulation occur

Engineering Contradiction:
Improvetransmission efficiencyVSAvoidinflammation and immune system stimulation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses non-viral polymeric carriers instead of viral vectors. These synthetic polymers are designed to be temporary, biodegradable delivery vehicles that perform their function and are eliminated, avoiding the persistent immune stimulation and inflammation caused by viral carriers while maintaining effective gene delivery capability

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent employs composite polymeric structures with specific functional groups (cationic groups for DNA binding, redox-sensitive disulfide bonds for intracellular release) to create non-viral carriers that achieve viral-level transmission efficiency without the harmful immune responses associated with viral vectors

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If non-viral vectors are used as carriers for gene delivery, then toxicity and immune system stimulation are reduced, but gene transfer efficiency decreases

Engineering Contradiction:
Improvetoxicity and immune system stimulationVSAvoidgene transfer efficiency
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent modifies the chemical parameters of non-viral polymers by incorporating redox-sensitive disulfide bonds and cationic functional groups in specific ratios, enabling these biocompatible carriers to achieve enhanced gene transfer efficiency comparable to viral vectors while maintaining low toxicity and immune responsiveness

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces redox-sensitive disulfide bonds as intermediary mechanisms that allow the non-viral polymer carrier to protect DNA during extracellular transport and then trigger controlled release inside the cell, bridging the efficiency gap between non-viral and viral delivery systems

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If traditional antibacterial agents are used, then some bacteria are affected, but drug-resistant bacteria are not eliminated

Engineering Contradiction:
Improveantibacterial effectVSAvoideffectiveness against drug-resistant bacteria
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent designs multifunctional polymeric nanoparticles that simultaneously exhibit antibacterial activity and gene delivery capability. These nanoparticles can target and eliminate drug-resistant bacteria through their cationic surface charge and membrane-disrupting properties while also serving as gene carriers, providing a universal solution for both antibacterial and gene therapy applications

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent creates nanoparticles with localized functional properties: cationic groups concentrated on the surface for bacterial membrane interaction and antibacterial activity, while redox-sensitive disulfide bonds are positioned within the polymer structure for intracellular DNA release, enabling different functions at different locations within the same carrier

Inventive Principle:
Principle #3Local quality

4Reliability

If gene delivery methods are used to transport nucleic acids, then genetic material can be delivered to cells, but nucleic acids are vulnerable to degradation by nucleases

Engineering Contradiction:
Improvegene delivery capabilityVSAvoidnucleic acid stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent uses polymeric nanoparticles as flexible protective shells that encapsulate and shield nucleic acids from nuclease degradation during transport through the bloodstream and cellular environments. The polymer coating acts as a protective barrier while allowing the genetic material to be delivered intact to the target cells

Inventive Principle:
Principle #30Flexible shells and thin films

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These nanoparticles effectively target and eliminate both gram-positive and gram-negative bacteria, exhibit strong antibacterial and anti-biofilm activity, and demonstrate high transfection efficiency and low cytotoxicity, making them suitable for gene delivery and antibacterial applications.

Implementation Method 1

the copolymer includes redox-sensitive disulfide bonds that enable redox-sensitive drug or gene release inside cells

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Data Source

PatentUS20240102051A1Multifunctional copolymeric nanoparticle
Publication Date: 2024.03.28 HOOSHMAND SEYYED EMAD
  • US20240102051A1 patent drawing
  • US20240102051A1 patent drawing
  • US20240102051A1 patent drawing

AI summary

A multifunctional copolymeric nanoparticle, including a plurality of 1,4-diazabicyclo[2.2.2]octane (DABCO) monomers crosslinked with a plurality of bromoacetyl cystamine (BBAC) monomers. Also, each of the plurality of DABCO monomers and each of the plurality of BBAC monomers alternate in sequence. the multifunctional copolymeric nanoparticle has a formula:wherein n is an integer between 5 and 40.